BR112012001098A2 - Método de cicatrização de feridas e modulação de cicatriz - Google Patents

Método de cicatrização de feridas e modulação de cicatriz

Info

Publication number
BR112012001098A2
BR112012001098A2 BRBR112012001098-0A BR112012001098A BR112012001098A2 BR 112012001098 A2 BR112012001098 A2 BR 112012001098A2 BR 112012001098 A BR112012001098 A BR 112012001098A BR 112012001098 A2 BR112012001098 A2 BR 112012001098A2
Authority
BR
Brazil
Prior art keywords
scar
modulation
wound healing
healing method
wound
Prior art date
Application number
BRBR112012001098-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Brian C Keller
Original Assignee
Crescendo Therapeutics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crescendo Therapeutics Llc filed Critical Crescendo Therapeutics Llc
Publication of BR112012001098A2 publication Critical patent/BR112012001098A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRBR112012001098-0A 2009-07-09 2010-07-09 Método de cicatrização de feridas e modulação de cicatriz BR112012001098A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22440809P 2009-07-09 2009-07-09
US22621609P 2009-07-16 2009-07-16
PCT/US2010/041576 WO2011006100A1 (en) 2009-07-09 2010-07-09 Method of wound healing and scar modulation

Publications (1)

Publication Number Publication Date
BR112012001098A2 true BR112012001098A2 (pt) 2015-09-01

Family

ID=43427950

Family Applications (1)

Application Number Title Priority Date Filing Date
BRBR112012001098-0A BR112012001098A2 (pt) 2009-07-09 2010-07-09 Método de cicatrização de feridas e modulação de cicatriz

Country Status (10)

Country Link
US (1) US20110009374A1 (https=)
EP (1) EP2451280A4 (https=)
JP (1) JP2012532889A (https=)
CN (1) CN102480969A (https=)
AR (1) AR077410A1 (https=)
AU (1) AU2010271205A1 (https=)
BR (1) BR112012001098A2 (https=)
CA (1) CA2767661A1 (https=)
MX (1) MX2012000434A (https=)
WO (1) WO2011006100A1 (https=)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100322875A1 (en) 2009-06-18 2010-12-23 Advanced Bio-Technologies, Inc. Silicone scar treatment preparation
US8623040B2 (en) 2009-07-01 2014-01-07 Alcon Research, Ltd. Phacoemulsification hook tip
WO2012012390A1 (en) 2010-07-19 2012-01-26 Marvphyt Development Llc Botanical composition and methods of manufacture and use
US10258505B2 (en) 2010-09-17 2019-04-16 Alcon Research, Ltd. Balanced phacoemulsification tip
ITMI20111050A1 (it) * 2011-06-10 2012-12-11 Sevecom Spa Uso di emulsionanti in associazione con oleine vegetali in un alimento per animali.
ES2622849T3 (es) 2011-06-24 2017-07-07 Merz Pharma Gmbh & Co. Kgaa Composición que comprende un extracto de cebolla y liposomas
US9364510B2 (en) 2011-07-19 2016-06-14 Marvphyt Development Llc Botanical composition and methods of manufacture and use
EP4234545A3 (en) 2011-07-29 2023-09-06 Karyopharm Therapeutics Inc. Hydrazide containing nuclear transport modulators and uses thereof
MX369385B (es) * 2011-09-13 2019-11-07 Univ Brigham Young Productos para cicatrizar heridas tisulares.
US9474685B2 (en) 2011-09-28 2016-10-25 Sure-Shot Medical Device Inc. Apparatus for localized dermatological treatment
GB201120724D0 (en) * 2011-12-01 2012-01-11 Gauthier Rene System and method for alleviating the appearance of scars and/or scar tissue
FR2985064B1 (fr) * 2011-12-23 2016-02-26 Oreal Procede pour delivrer un conseil cosmetique
EP2841106A1 (en) * 2012-04-27 2015-03-04 Dow Corning Corporation Topical formulation compositions containing silicone based excipients to deliver actives to a substrate
WO2013170068A2 (en) 2012-05-09 2013-11-14 Karyopharm Therapeutics, Inc. Nuclear transport modulators and uses thereof
US11458199B2 (en) * 2012-08-21 2022-10-04 Opko Pharmaceuticals, Llc Liposome formulations
US9808654B2 (en) * 2013-02-11 2017-11-07 Jan Marini Skin Research Post procedure skin care gel and methods of use thereof
EP2968278B8 (en) * 2013-03-15 2019-05-22 Karyopharm Therapeutics Inc. Methods of promoting wound healing using crm1 inhibitors
CN105122261B (zh) * 2013-04-23 2020-04-24 惠普发展公司，有限责任合伙企业 从遭到破坏的系统启动代码中恢复的方法以及计算装置
ME03421B (me) 2013-06-21 2020-01-20 Karyopharm Therapeutics Inc 1,2,4-triazoli kao modulatori nuklearnog transporta i njihova upotreba
US11432990B2 (en) 2013-08-30 2022-09-06 ISOS Solutions, LLC Textured apparatus with therapeutic material incorporated therein and methods of manufacturing same
US9226890B1 (en) 2013-12-10 2016-01-05 Englewood Lab, Llc Polysilicone base for scar treatment
EP3087495A4 (en) * 2013-12-23 2017-08-23 Intel Corporation Integrated component interconnect
WO2015189712A2 (en) * 2014-06-09 2015-12-17 Klox Technologies Inc. Silicone-based biophotonic compositions and uses thereof
BR112017000878B1 (pt) 2014-07-21 2022-05-10 Sevecom S.P.A. Mistura sólida, seu uso, e alimento para animal
KR102608259B1 (ko) 2014-08-15 2023-11-29 카리오팜 쎄라퓨틱스, 인코포레이티드 셀리넥소의 다형태
EP3397634A1 (en) 2015-12-31 2018-11-07 Karyopharm Therapeutics, Inc. Nuclear transport modulators and uses thereof
US10526295B2 (en) 2015-12-31 2020-01-07 Karyopharm Therapeutics Inc. Nuclear transport modulators and uses thereof
US11602530B2 (en) 2016-11-28 2023-03-14 Biogen Ma Inc. CRM1 inhibitors for treating epilepsy
EP3548035A4 (en) * 2016-11-30 2020-07-22 Case Western Reserve University COMBINATIONS OF 15-PGDH INHIBITORS WITH CORCOSTEROIDS AND / OR TNF INHIBITORS AND THEIR USES
JP2020514323A (ja) 2017-02-06 2020-05-21 ケース ウエスタン リザーブ ユニバーシティ 短鎖デヒドロゲナーゼ活性を調節する組成物と方法
CN113453670A (zh) * 2018-09-28 2021-09-28 乔·斯图丁 类固醇和大分子的透孔递送
KR102921276B1 (ko) 2018-11-21 2026-02-03 케이스 웨스턴 리저브 유니버시티 단쇄 데히드로게나아제 활성을 조절하는 조성물 및 방법
US20200397720A1 (en) * 2019-06-23 2020-12-24 Charles Huntington Gallina Method and formulation for treatment of wounds by new tissue regeneration with reduced trauma and scar tissue formation
CN110368498A (zh) * 2019-08-26 2019-10-25 瑞希(重庆)生物科技有限公司 一种促进伤口愈合的制剂及其制备方法
IL319751A (en) * 2022-07-27 2025-05-01 Bio Medical Sciences Inc Method for improving results of dermal tattoos and tattoo removal procedures

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6337076B1 (en) * 1999-11-17 2002-01-08 Sg Licensing Corporation Method and composition for the treatment of scars
KR100362924B1 (ko) * 2000-01-11 2002-11-30 주식회사 동구약품 외피용약제 조성물
AU2001256347A1 (en) * 2000-05-23 2001-12-03 Unilever Plc Deodorant and/or antiperspirant compositions
GB0018466D0 (en) * 2000-07-27 2000-09-13 Strakan Pharm Ltd Keloid Treatment
US6610322B1 (en) * 2000-12-20 2003-08-26 Brian Charles Keller Self forming, thermodynamically stable liposomes and their applications
US6998421B2 (en) * 2001-06-07 2006-02-14 Biozone Laboratories, Inc. Compounds and methods for inhibition of phospholipase A2 and cyclooxygenase - 2
US6495596B1 (en) * 2001-03-23 2002-12-17 Biozibe Laboratories, Inc. Compounds and methods for inhibition of phospholipase A2 and cyclooxygenase-2
JP4450545B2 (ja) * 2001-07-05 2010-04-14 ロート製薬株式会社 エアゾール製剤
JP4549006B2 (ja) * 2002-05-07 2010-09-22 ロート製薬株式会社 ゲル軟膏
GB0216427D0 (en) * 2002-07-16 2002-08-21 Advanced Biotechnologies Inter Wound dressing
US20040220155A1 (en) * 2003-03-28 2004-11-04 Pharmacia Corporation Method of providing a steroid-sparing benefit with a cyclooxygenase-2 inhibitor and compositions therewith
US20050014729A1 (en) * 2003-07-16 2005-01-20 Pharmacia Corporation Method for the treatment or prevention of dermatological disorders with a cyclooxygenase-2 inhibitor alone and in combination with a dermatological treatment agent and compositions therewith
AU2005253735A1 (en) * 2004-06-17 2005-12-29 Galderma S.A. Composition for the treatment of psoriasis comprising a silicone agent, a corticosteroid and vitamin D or a derivative thereof
MX2007015672A (es) * 2005-06-10 2008-02-20 Galderma Sa Liberacion controlada de un farmaco a traves de la piel sobre la base de una composicion topica que comprende el farmaco, una silicona formadora de pelicula y al menos un solvente volatil.
MX2009009557A (es) * 2007-03-08 2010-08-10 Crescendo Therapeutics Llc Formulaciones de aposito para prevenir o reducir la cicatrizacion.
US20080317830A1 (en) * 2007-06-25 2008-12-25 Liolabs Llc Compositions and Methods for the Treatment of Wounds and Scar Tissue
DE102009030931A1 (de) * 2009-06-24 2010-12-30 Eberhard-Karls-Universität Tübingen Universitätsklinikum Chirurgisches Wundverschlusselement

Also Published As

Publication number Publication date
AU2010271205A1 (en) 2012-02-09
JP2012532889A (ja) 2012-12-20
CN102480969A (zh) 2012-05-30
MX2012000434A (es) 2012-04-11
CA2767661A1 (en) 2011-01-13
EP2451280A1 (en) 2012-05-16
AR077410A1 (es) 2011-08-24
EP2451280A4 (en) 2012-12-26
WO2011006100A1 (en) 2011-01-13
US20110009374A1 (en) 2011-01-13

Similar Documents

Publication Publication Date Title
BR112012001098A2 (pt) Método de cicatrização de feridas e modulação de cicatriz
BRPI1013655A8 (pt) dispositivo e método cirúrgico
BR112013013584A2 (pt) endoscópio, e, método
EP2442833A4 (en) Wound healing device
PL2490940T3 (pl) System i metoda bsp
BRPI0910259A2 (pt) métodos de tratamento de inflamação
EP2413725A4 (en) WRIST BRACE
BR112013008522A2 (pt) dispositivo de comunicação e método de comunicação
EP2405749A4 (en) THERAPY TO LOW FREQUENCY GLATIRAMERATE ACETATE
PT3247159T (pt) Aparelhos de radiocomunicação e método de radiocomunicação
BRPI0915593A2 (pt) Curativo de ferida
EP2488250A4 (en) ENERGETIC NERVE MODULATION
BR112012031446A2 (pt) componentes e métodos para implantes
EP2515787A4 (en) SURGICAL GUIDANCE AND METHOD THEREFOR
DK2538984T3 (da) Kompressionsforbinding
BRPI0912281A2 (pt) curativo de feridas
FR2960763B1 (fr) Implant de suture
BR112012027159A2 (pt) estrutura e método
DE102011050218B8 (de) Ein-Chip-System, Vorrichtungen mit demselben und Verfahren zur Leistungssteuerung des Ein-Chip-Systems
BRPI1007909A2 (pt) método e dispositivo médico
EP2519186A4 (en) IMPLANTABLE SCARF SYSTEMS AND ASSOCIATED METHODS
FI20090357L (fi) Menetelmä ja järjestely
BRPI1011397A2 (pt) atenuador
EP2496264A4 (en) Composition for promoting wound healing
EP2566483A4 (en) METHOD AND MEANS FOR IMPROVED WOUND HEALING

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2522 DE 07-05-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.